Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +47.56%
#3 Cysic Cysic +41.67%
#4 Glidr Glidr +36.41%
#5 Walrus Walrus +29.37%
#6 Humanity Humanity +23.38%
#7 Codatta Codatta +16.38%
#8 Enso Enso +16.32%
#9 Tutorial Tutorial +15.81%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.43%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Rang in aandelen #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Aandeelprijs
$0.2488447
Laatst gesynchroniseerd: 2024-10-01
Marktkapitalisatie
$2.01M
Verandering (1 dag)
-1.88%
Verandering (1 jaar)
0.00%
Land
IN
Handel Ortin Laboratories Limited (ORTINLAB)

Categorie

Healthcare
Aantal uitstaande aandelen voor Ortin Laboratories Limited (ORTINLAB)
Aantal uitstaande aandelen per June 2024: 8.13M
Volgens de laatste financiële rapporten en de aandelenkoers van Ortin Laboratories Limited bedraagt het huidige aantal uitstaande aandelen 8.13M. Aan het einde van March 2023 had het bedrijf 8.13M uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Ortin Laboratories Limited (ORTINLAB) van 2008 tot 2026
Uitstaande aandelen aan het einde van elk jaar
Jaar Uitstaande aandelen Wijzigen
2026 (TTM) 8.13M 0.01%
2024 8.13M -0.01%
2023 8.13M 0.00%
2022 8.13M -0.23%
2021 8.15M 0.24%
2020 8.13M 0.00%
2019 8.13M 0.00%
2018 8.13M 0.00%
2017 8.13M 0.00%
2016 8.13M -0.01%
2015 8.13M -0.04%
2014 8.14M -0.70%
2013 8.19M 0.23%
2012 8.17M 0.52%
2011 8.13M 361.54%
2010 1.76M 0.00%
2009 1.76M -0.01%
2008 1.76M 0.00%
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
Bedrijf Uitstaande aandelen Verschil Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 29,407.06%
IN